ArticleBlood2009

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

Abdel Kareem Azab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.